{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:40:05Z","timestamp":1790095205885,"version":"4.0.1"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,14]]},"DOI":"10.7759\/cureus.85988","type":"journal-article","created":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T10:24:22Z","timestamp":1749896662000},"source":"Crossref","is-referenced-by-count":3,"title":["Role of Genetics in Early-Onset Cardiovascular Disease"],"prefix":"10.7759","author":[{"given":"Muhammad","family":"Meer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhsina","family":"Meer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahnoor","family":"Mumtaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umar","family":"Jawed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Cardiovascular diseases (CVDs). (2021). Accessed. June 10, 2025: https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/cardiovascular-diseases-(cvds)."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001052","article-title":"Heart disease and stroke statistics-2022 update: a report from the American Heart Association","volume":"145","author":"Tsao CW","year":"2022","unstructured":"Tsao CW, Aday AW, Almarzooq ZI, et al.. Heart disease and stroke statistics-2022 update: a report from the American Heart Association. Circulation. 2022, 145:e153-639. 10.1161\/CIR.0000000000001052","journal-title":"Circulation"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000530","article-title":"Correction to: heart disease and stroke statistics-2017 update: a report from the American Heart Association","volume":"136","year":"2017","unstructured":"Correction to. heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation. 2017, 136:e196. 10.1161\/CIR.0000000000000530","journal-title":"Circulation"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000659","article-title":"Heart disease and stroke statistics-2019 update: a report from the American Heart Association","volume":"139","author":"Benjamin EJ","year":"2019","unstructured":"Benjamin EJ, Muntner P, Alonso A, et al.. Heart disease and stroke statistics-2019 update: a report from the American Heart Association. Circulation. 2019, 139:e56-e528. 10.1161\/CIR.0000000000000659","journal-title":"Circulation"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.035658","article-title":"Whole-genome sequencing to characterize monogenic and polygenic contributions in patients hospitalized with early-onset myocardial infarction","volume":"139","author":"Khera AV","year":"2019","unstructured":"Khera AV, Chaffin M, Zekavat SM, et al.. Whole-genome sequencing to characterize monogenic and polygenic contributions in patients hospitalized with early-onset myocardial infarction. Circulation. 2019, 139:1593-602. 10.1161\/CIRCULATIONAHA.118.035658","journal-title":"Circulation"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1126\/science.abi8206","article-title":"Discovery and implications of polygenicity of common diseases","volume":"373","author":"Visscher PM","year":"2021","unstructured":"Visscher PM, Yengo L, Cox NJ, Wray NR. Discovery and implications of polygenicity of common diseases. Science. 2021, 373:1468-73. 10.1126\/science.abi8206","journal-title":"Science"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2019.5954","article-title":"Association of monogenic vs polygenic hypercholesterolemia with risk of atherosclerotic cardiovascular disease","volume":"5","author":"Trinder M","year":"2020","unstructured":"Trinder M, Francis GA, Brunham LR. Association of monogenic vs polygenic hypercholesterolemia with risk of atherosclerotic cardiovascular disease. JAMA Cardiol. 2020, 5:390-9. 10.1001\/jamacardio.2019.5954","journal-title":"JAMA Cardiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.118.313171","article-title":"Lipid-lowering agents: targets beyond PCSK9","volume":"124","author":"Hegele RA","year":"2019","unstructured":"Hegele RA, Tsimikas S. Lipid-lowering agents: targets beyond PCSK9. Circ Res. 2019, 124:386-404. 10.1161\/CIRCRESAHA.118.313171","journal-title":"Circ Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.006511","article-title":"Use of contemporary genetics in cardiovascular diagnosis","volume":"130","author":"George AL Jr","year":"2014","unstructured":"George AL Jr. Use of contemporary genetics in cardiovascular diagnosis. Circulation. 2014, 130:1971-80. 10.1161\/CIRCULATIONAHA.114.006511","journal-title":"Circulation"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.02.015","article-title":"Genetics of common, complex coronary artery disease","volume":"177","author":"Musunuru K","year":"2019","unstructured":"Musunuru K, Kathiresan S. Genetics of common, complex coronary artery disease. Cell. 2019, 177:132-45. 10.1016\/j.cell.2019.02.015","journal-title":"Cell"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001077","article-title":"Polygenic risk scores for cardiovascular disease: a scientific statement from the American Heart Association","volume":"146","author":"O'Sullivan JW","year":"2022","unstructured":"O'Sullivan JW, Raghavan S, Marquez-Luna C, et al.. Polygenic risk scores for cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2022, 146:e93-e118. 10.1161\/CIR.0000000000001077","journal-title":"Circulation"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study","volume":"76","author":"Roth GA","year":"2020","unstructured":"Roth GA, Mensah GA, Johnson CO, et al.. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020, 76:2982-3021. 10.1016\/j.jacc.2020.11.010","journal-title":"J Am Coll Cardiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.10.009","article-title":"The global burden of cardiovascular diseases and risk factors: 2020 and beyond","volume":"74","author":"Mensah GA","year":"2019","unstructured":"Mensah GA, Roth GA, Fuster V. The global burden of cardiovascular diseases and risk factors: 2020 and beyond. J Am Coll Cardiol. 2019, 74:2529-32. 10.1016\/j.jacc.2019.10.009","journal-title":"J Am Coll Cardiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3156.2008.02116.x","article-title":"Non-communicable diseases in low- and middle-income countries: context, determinants and health policy","volume":"13","author":"Miranda JJ","year":"2008","unstructured":"Miranda JJ, Kinra S, Casas JP, Davey Smith G, Ebrahim S. Non-communicable diseases in low- and middle-income countries: context, determinants and health policy. Trop Med Int Health. 2008, 13:1225-34. 10.1111\/j.1365-3156.2008.02116.x","journal-title":"Trop Med Int Health"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2009.10.002","article-title":"Growing epidemic of coronary heart disease in low- and middle-income countries","volume":"35","author":"Gaziano TA","year":"2010","unstructured":"Gaziano TA, Bitton A, Anand S, Abrahams-Gessel S, Murphy A. Growing epidemic of coronary heart disease in low- and middle-income countries. Curr Probl Cardiol. 2010, 35:72-115. 10.1016\/j.cpcardiol.2009.10.002","journal-title":"Curr Probl Cardiol"},{"key":"ref16","article-title":"The global economic burden of noncommunicable diseases","author":"Bloom DE","year":"2011","unstructured":"Bloom DE, Cafiero ET, Jan\u00e9-Llopis E, et al.. The global economic burden of noncommunicable diseases. World Economic Forum, Geneva; 2011."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61682-2","article-title":"Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"385","author":"GBD 2013 Mortality and Causes of Death Collaborators","year":"2015","unstructured":"GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015, 385:117-71. 10.1016\/S0140-6736(14)61682-2","journal-title":"Lancet"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2020.108717","article-title":"PCSK9: associated with cardiac diseases and their risk factors?","volume":"704","author":"Guo Y","year":"2021","unstructured":"Guo Y, Yan B, Tai S, Zhou S, Zheng XL. PCSK9: associated with cardiac diseases and their risk factors?. Arch Biochem Biophys. 2021, 704:108717. 10.1016\/j.abb.2020.108717","journal-title":"Arch Biochem Biophys"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/nrg.2018.4","article-title":"Integrative omics for health and disease","volume":"19","author":"Karczewski KJ","year":"2018","unstructured":"Karczewski KJ, Snyder MP. Integrative omics for health and disease. Nat Rev Genet. 2018, 19:299-310. 10.1038\/nrg.2018.4","journal-title":"Nat Rev Genet"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s40246-014-0023-x","article-title":"Self-reported race\/ethnicity in the age of genomic research: its potential impact on understanding health disparities","volume":"9","author":"Mersha TB","year":"2015","unstructured":"Mersha TB, Abebe T. Self-reported race\/ethnicity in the age of genomic research: its potential impact on understanding health disparities. Hum Genomics. 2015, 9:1. 10.1186\/s40246-014-0023-x","journal-title":"Hum Genomics"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/475163a","article-title":"Genomics for the world","volume":"475","author":"Bustamante CD","year":"2011","unstructured":"Bustamante CD, Burchard EG, de la Vega FM. Genomics for the world. Nature. 2011, 475:163-5. 10.1038\/475163a","journal-title":"Nature"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000437913.98912.1d","article-title":"Genetics and genomics for the prevention and treatment of cardiovascular disease: update: a scientific statement from the American Heart Association","volume":"128","author":"Ganesh SK","year":"2013","unstructured":"Ganesh SK, Arnett DK, Assimes TL, et al.. Genetics and genomics for the prevention and treatment of cardiovascular disease: update: a scientific statement from the American Heart Association. Circulation. 2013, 128:2813-51. 10.1161\/01.cir.0000437913.98912.1d","journal-title":"Circulation"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1215-1","article-title":"Multi-omics approaches to disease","volume":"18","author":"Hasin Y","year":"2017","unstructured":"Hasin Y, Seldin M, Lusis A. Multi-omics approaches to disease. Genome Biol. 2017, 18:83. 10.1186\/s13059-017-1215-1","journal-title":"Genome Biol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.05.003","article-title":"Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine","volume":"64","author":"Maron BJ","year":"2014","unstructured":"Maron BJ, Ommen SR, Semsarian C, Spirito P, Olivotto I, Maron MS. Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine. J Am Coll Cardiol. 2014, 64:83-99. 10.1016\/j.jacc.2014.05.003","journal-title":"J Am Coll Cardiol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGENETICS.116.001573","article-title":"Application of whole exome sequencing in the clinical diagnosis and management of inherited cardiovascular diseases in adults","volume":"10","author":"Seidelmann SB","year":"2017","unstructured":"Seidelmann SB, Smith E, Subrahmanyan L, et al.. Application of whole exome sequencing in the clinical diagnosis and management of inherited cardiovascular diseases in adults. Circ Cardiovasc Genet. 2017, 10:10.1161\/CIRCGENETICS.116.001573","journal-title":"Circ Cardiovasc Genet"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2021.04.011","article-title":"A new era of genetic testing in congenital heart disease: a review","volume":"32","author":"Morrish AM","year":"2022","unstructured":"Morrish AM, Smith J, Enriquez A, et al.. A new era of genetic testing in congenital heart disease: a review. Trends Cardiovasc Med. 2022, 32:311-9. 10.1016\/j.tcm.2021.04.011","journal-title":"Trends Cardiovasc Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20236015","article-title":"On the road to accurate biomarkers for cardiometabolic diseases by integrating precision and gender medicine approaches","volume":"20","author":"Scola L","year":"2019","unstructured":"Scola L, Giarratana RM, Torre S, Argano V, Lio D, Balistreri CR. On the road to accurate biomarkers for cardiometabolic diseases by integrating precision and gender medicine approaches. Int J Mol Sci. 2019, 20:6015. 10.3390\/ijms20236015","journal-title":"Int J Mol Sci"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2005.03.016","article-title":"Changing trends in the long-term prognosis of patients with acute myocardial infarction: a population-based perspective","volume":"151","author":"Botkin NF","year":"2006","unstructured":"Botkin NF, Spencer FA, Goldberg RJ, Lessard D, Yarzebski J, Gore JM. Changing trends in the long-term prognosis of patients with acute myocardial infarction: a population-based perspective. Am Heart J. 2006, 151:199-205. 10.1016\/j.ahj.2005.03.016","journal-title":"Am Heart J"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.025941","article-title":"Age-specific trends in incidence, mortality, and comorbidities of heart failure in Denmark, 1995 to 2012","volume":"135","author":"Christiansen MN","year":"2017","unstructured":"Christiansen MN, K\u00f8ber L, Weeke P, et al.. Age-specific trends in incidence, mortality, and comorbidities of heart failure in Denmark, 1995 to 2012. Circulation. 2017, 135:1214-23. 10.1161\/CIRCULATIONAHA.116.025941","journal-title":"Circulation"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.acvd.2018.01.002","article-title":"Temporal trends in clinical characteristics and management according to sex in patients with cardiogenic shock after acute myocardial infarction: the FAST-MI programme","volume":"111","author":"Isorni MA","year":"2018","unstructured":"Isorni MA, Aissaoui N, Angoulvant D, et al.. Temporal trends in clinical characteristics and management according to sex in patients with cardiogenic shock after acute myocardial infarction: the FAST-MI programme. Arch Cardiovasc Dis. 2018, 111:555-63. 10.1016\/j.acvd.2018.01.002","journal-title":"Arch Cardiovasc Dis"},{"key":"ref31","doi-asserted-by":"crossref","DOI":"10.18773\/austprescr.2013.077","article-title":"Cardiovascular drugs in older people","volume":"36","author":"Naganathan V","year":"2013","unstructured":"Naganathan V. Cardiovascular drugs in older people. Aust Prescr. 2013, 36:","journal-title":"Aust Prescr"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2013.301226","article-title":"The decline and rise of coronary heart disease: understanding public health catastrophism","volume":"103","author":"Jones DS","year":"2013","unstructured":"Jones DS, Greene JA. The decline and rise of coronary heart disease: understanding public health catastrophism. Am J Public Health. 2013, 103:1207-18. 10.2105\/AJPH.2013.301226","journal-title":"Am J Public Health"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw106","article-title":"2016 European guidelines on cardiovascular disease prevention in clinical practice: the sixth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts)","volume":"37","author":"Piepoli MF","year":"2016","unstructured":"Piepoli MF, Hoes AW, Agewall S, et al.. 2016 European guidelines on cardiovascular disease prevention in clinical practice: the sixth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts). Eur Heart J. 2016, 37:2315-81. 10.1093\/eurheartj\/ehw106","journal-title":"Eur Heart J"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.800235","article-title":"Prevalence and progression of subclinical atherosclerosis in younger adults with low short-term but high lifetime estimated risk for cardiovascular disease: the coronary artery risk development in young adults study and multi-ethnic study of atherosclerosis","volume":"119","author":"Berry JD","year":"2009","unstructured":"Berry JD, Liu K, Folsom AR, et al.. Prevalence and progression of subclinical atherosclerosis in younger adults with low short-term but high lifetime estimated risk for cardiovascular disease: the coronary artery risk development in young adults study and multi-ethnic study of atherosclerosis. Circulation. 2009, 119:382-9. 10.1161\/CIRCULATIONAHA.108.800235","journal-title":"Circulation"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60460-8","article-title":"Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"384","author":"Ng M","year":"2014","unstructured":"Ng M, Fleming T, Robinson M, et al.. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014, 384:766-81. 10.1016\/S0140-6736(14)60460-8","journal-title":"Lancet"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32129-3","article-title":"Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128\u00b79 million children, adolescents, and adults","volume":"390","author":"NCD Risk Factor Collaboration","year":"2017","unstructured":"NCD Risk Factor Collaboration. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128\u00b79 million children, adolescents, and adults. Lancet. 2017, 390:2627-42. 10.1016\/S0140-6736(17)32129-3","journal-title":"Lancet"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60646-1","article-title":"Global physical activity levels: surveillance progress, pitfalls, and prospects","volume":"380","author":"Hallal PC","year":"2012","unstructured":"Hallal PC, Andersen LB, Bull FC, Guthold R, Haskell W, Ekelund U. Global physical activity levels: surveillance progress, pitfalls, and prospects. Lancet. 2012, 380:247-57. 10.1016\/S0140-6736(12)60646-1","journal-title":"Lancet"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1177\/0003319718780145","article-title":"Cardiovascular safety of psychiatric agents: a cautionary tale","volume":"70","author":"Manolis TA","year":"2019","unstructured":"Manolis TA, Manolis AA, Manolis AS. Cardiovascular safety of psychiatric agents: a cautionary tale. Angiology. 2019, 70:103-29. 10.1177\/0003319718780145","journal-title":"Angiology"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2021.1903649","article-title":"State-led opioid overdose prevention efforts: challenges, solutions and lessons learned from the CDC Prevention for States Program (PfS)","volume":"42","author":"Underwood N","year":"2021","unstructured":"Underwood N, Rooks-Peck C, Ali N, et al.. State-led opioid overdose prevention efforts: challenges, solutions and lessons learned from the CDC Prevention for States Program (PfS). Subst Abus. 2021, 42:227-35. 10.1080\/08897077.2021.1903649","journal-title":"Subst Abus"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1111\/add.12899","article-title":"Global statistics on addictive behaviours: 2014 status report","volume":"110","author":"Gowing LR","year":"2015","unstructured":"Gowing LR, Ali RL, Allsop S, Marsden J, Turf EE, West R, Witton J. Global statistics on addictive behaviours: 2014 status report. Addiction. 2015, 110:904-19. 10.1111\/add.12899","journal-title":"Addiction"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1002\/humu.1380010602","article-title":"Molecular genetics of the LDL receptor gene in familial hypercholesterolemia","volume":"1","author":"Hobbs HH","year":"1992","unstructured":"Hobbs HH, Brown MS, Goldstein JL. Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum Mutat. 1992, 1:445-66. 10.1002\/humu.1380010602","journal-title":"Hum Mutat"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.01.036","article-title":"A century of cholesterol and coronaries: from plaques to genes to statins","volume":"161","author":"Goldstein JL","year":"2015","unstructured":"Goldstein JL, Brown MS. A century of cholesterol and coronaries: from plaques to genes to statins. Cell. 2015, 161:161-72. 10.1016\/j.cell.2015.01.036","journal-title":"Cell"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.2174\/1566524013364194","article-title":"The human ATP-binding cassette transporter genes: from the bench to the bedside","volume":"1","author":"Efferth T","year":"2001","unstructured":"Efferth T. The human ATP-binding cassette transporter genes: from the bench to the bedside. Curr Mol Med. 2001, 1:45-65. 10.2174\/1566524013364194","journal-title":"Curr Mol Med"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000678","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines","volume":"140","author":"Arnett DK","year":"2019","unstructured":"Arnett DK, Blumenthal RS, Albert MA, et al.. 2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines. Circulation. 2019, 140:e596-646. 10.1161\/CIR.0000000000000678","journal-title":"Circulation"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.117.311059","article-title":"Hypertrophic cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy","volume":"121","author":"Marian AJ","year":"2017","unstructured":"Marian AJ, Braunwald E. Hypertrophic cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy. Circ Res. 2017, 121:749-70. 10.1161\/CIRCRESAHA.117.311059","journal-title":"Circ Res"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.665406","article-title":"Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene","volume":"115","author":"Moss AJ","year":"2007","unstructured":"Moss AJ, Shimizu W, Wilde AA, et al.. Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene. Circulation. 2007, 115:2481-9. 10.1161\/CIRCULATIONAHA.106.665406","journal-title":"Circulation"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.03.325","article-title":"Precision medicine approaches to cardiac arrhythmias: JACC focus seminar 4\/5","volume":"77","author":"Giudicessi JR","year":"2021","unstructured":"Giudicessi JR, Ackerman MJ, Fatkin D, Kovacic JC. Precision medicine approaches to cardiac arrhythmias: JACC focus seminar 4\/5. J Am Coll Cardiol. 2021, 77:2573-91. 10.1016\/j.jacc.2021.03.325","journal-title":"J Am Coll Cardiol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2012.10.010","article-title":"Genetics 101 for cardiologists: rare genetic variants and monogenic cardiovascular disease","volume":"29","author":"Farhan SM","year":"2013","unstructured":"Farhan SM, Hegele RA. Genetics 101 for cardiologists: rare genetic variants and monogenic cardiovascular disease. Can J Cardiol. 2013, 29:18-22. 10.1016\/j.cjca.2012.10.010","journal-title":"Can J Cardiol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-021-01540-0","article-title":"Monogenic and polygenic models of coronary artery disease","volume":"23","author":"Muse ED","year":"2021","unstructured":"Muse ED, Chen SF, Torkamani A. Monogenic and polygenic models of coronary artery disease. Curr Cardiol Rep. 2021, 23:107. 10.1007\/s11886-021-01540-0","journal-title":"Curr Cardiol Rep"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2023.0857","article-title":"Cardiovascular disease risk assessment using traditional risk factors and polygenic risk scores in the Million Veteran Program","volume":"8","author":"Vassy JL","year":"2023","unstructured":"Vassy JL, Posner DC, Ho YL, et al.. Cardiovascular disease risk assessment using traditional risk factors and polygenic risk scores in the Million Veteran Program. JAMA Cardiol. 2023, 8:564-74. 10.1001\/jamacardio.2023.0857","journal-title":"JAMA Cardiol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.018932","article-title":"Clinical implications of monogenic versus polygenic hypercholesterolemia: long-term response to treatment, coronary atherosclerosis burden, and cardiovascular events","volume":"10","author":"D'Erasmo L","year":"2021","unstructured":"D'Erasmo L, Minicocci I, Di Costanzo A, et al.. Clinical implications of monogenic versus polygenic hypercholesterolemia: long-term response to treatment, coronary atherosclerosis burden, and cardiovascular events. J Am Heart Assoc. 2021, 10:e018932. 10.1161\/JAHA.120.018932","journal-title":"J Am Heart Assoc"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2022.100068","article-title":"Clinical implementation of combined monogenic and polygenic risk disclosure for coronary artery disease","volume":"1","author":"Maamari DJ","year":"2022","unstructured":"Maamari DJ, Brockman DG, Aragam K, et al.. Clinical implementation of combined monogenic and polygenic risk disclosure for coronary artery disease. JACC Adv. 2022, 1:100068. 10.1016\/j.jacadv.2022.100068","journal-title":"JACC Adv"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddl060","article-title":"Lessons from studying monogenic disease for common disease","volume":"15","author":"Peltonen L","year":"2006","unstructured":"Peltonen L, Perola M, Naukkarinen J, Palotie A. Lessons from studying monogenic disease for common disease. Hum Mol Genet. 2006, 15:R67-74. 10.1093\/hmg\/ddl060","journal-title":"Hum Mol Genet"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijdm.2009.05.003","article-title":"Identification of loci conferring risk for premature CAD and heterozygous familial hyperlipidemia in the LDLR, APOB and PCSK9 genes","volume":"1","author":"Muiya P","year":"2009","unstructured":"Muiya P, Wakil S, Al-Najai M, Meyer BF, Al-Mohanna F, Alshahid M, Dzimiri N. Identification of loci conferring risk for premature CAD and heterozygous familial hyperlipidemia in the LDLR, APOB and PCSK9 genes. Int J Diabetes Mellitus. 2009, 1:16-21. 10.1016\/j.ijdm.2009.05.003","journal-title":"Int J Diabetes Mellitus"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1097\/HCO.0000000000000676","article-title":"Genetics of early-onset coronary artery disease: from discovery to clinical translation","volume":"34","author":"Lali R","year":"2019","unstructured":"Lali R, Cui E, Ansarikaleibari A, Pigeyre M, Par\u00e9 G. Genetics of early-onset coronary artery disease: from discovery to clinical translation. Curr Opin Cardiol. 2019, 34:706-13. 10.1097\/HCO.0000000000000676","journal-title":"Curr Opin Cardiol"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-021-07168-0","article-title":"Genetics of triglyceride-rich lipoproteins guide identification of pharmacotherapy for cardiovascular risk reduction","volume":"35","author":"Shaik A","year":"2021","unstructured":"Shaik A, Rosenson RS. Genetics of triglyceride-rich lipoproteins guide identification of pharmacotherapy for cardiovascular risk reduction. Cardiovasc Drugs Ther. 2021, 35:677-90. 10.1007\/s10557-021-07168-0","journal-title":"Cardiovasc Drugs Ther"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.34172\/apb.2020.062","article-title":"PCSK9: A key target for the treatment of cardiovascular disease (CVD)","volume":"10","author":"Sobati S","year":"2020","unstructured":"Sobati S, Shakouri A, Edalati M, Mohammadnejad D, Parvan R, Masoumi J, Abdolalizadeh J. PCSK9: A key target for the treatment of cardiovascular disease (CVD). Adv Pharm Bull. 2020, 10:502-11. 10.34172\/apb.2020.062","journal-title":"Adv Pharm Bull"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvw053","article-title":"Human PCSK9 promotes hepatic lipogenesis and atherosclerosis development via apoE- and LDLR-mediated mechanisms","volume":"110","author":"Tavori H","year":"2016","unstructured":"Tavori H, Giunzioni I, Predazzi IM, et al.. Human PCSK9 promotes hepatic lipogenesis and atherosclerosis development via apoE- and LDLR-mediated mechanisms. Cardiovasc Res. 2016, 110:268-78. 10.1093\/cvr\/cvw053","journal-title":"Cardiovasc Res"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.21037\/acs.2017.11.03","article-title":"Differences in manifestations of Marfan syndrome, Ehlers-Danlos syndrome, and Loeys-Dietz syndrome","volume":"6","author":"Meester JA","year":"2017","unstructured":"Meester JA, Verstraeten A, Schepers D, Alaerts M, Van Laer L, Loeys BL. Differences in manifestations of Marfan syndrome, Ehlers-Danlos syndrome, and Loeys-Dietz syndrome. Ann Cardiothorac Surg. 2017, 6:582-94. 10.21037\/acs.2017.11.03","journal-title":"Ann Cardiothorac Surg"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196509022731002","article-title":"Ehlers-Danlos syndrome occurring together with the Marfan syndrome. Report of a case with other family members affected","volume":"273","author":"Goodman RM","year":"1965","unstructured":"Goodman RM, Wooley CF, Frazier RL, Covault L. Ehlers-Danlos syndrome occurring together with the Marfan syndrome. Report of a case with other family members affected. N Engl J Med. 1965, 273:514-19. 10.1056\/NEJM196509022731002","journal-title":"N Engl J Med"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.c.31550","article-title":"The Ehlers-Danlos syndromes, rare types","volume":"175","author":"Brady AF","year":"2017","unstructured":"Brady AF, Demirdas S, Fournel-Gigleux S, et al.. The Ehlers-Danlos syndromes, rare types. Am J Med Genet C Semin Med Genet. 2017, 175:70-115. 10.1002\/ajmg.c.31550","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(87)90448-7","article-title":"Cardiovascular disease of connective tissue origin","volume":"82","author":"Bowen J","year":"1987","unstructured":"Bowen J, Boudoulas H, Wooley CF. Cardiovascular disease of connective tissue origin. Am J Med. 1987, 82:481-8. 10.1016\/0002-9343(87)90448-7","journal-title":"Am J Med"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2020.100077","article-title":"Ehlers-Danlos Syndrome: immunologic contrasts and connective tissue comparisons","volume":"4","author":"Islam M","year":"2021","unstructured":"Islam M, Chang C, Gershwin ME. Ehlers-Danlos Syndrome: immunologic contrasts and connective tissue comparisons. J Transl Autoimmun. 2021, 4:100077. 10.1016\/j.jtauto.2020.100077","journal-title":"J Transl Autoimmun"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1080\/14737159.2017.1332997","article-title":"Recent advances in genetic testing for familial hypercholesterolemia","volume":"17","author":"Iacocca MA","year":"2017","unstructured":"Iacocca MA, Hegele RA. Recent advances in genetic testing for familial hypercholesterolemia. Expert Rev Mol Diagn. 2017, 17:641-51. 10.1080\/14737159.2017.1332997","journal-title":"Expert Rev Mol Diagn"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-019-02088-4","article-title":"The current and future impact of genome-wide sequencing on fetal precision medicine","volume":"139","author":"Sabbagh R","year":"2020","unstructured":"Sabbagh R, van den Veyver IB. The current and future impact of genome-wide sequencing on fetal precision medicine. Hum Genet. 2020, 139:1121-30. 10.1007\/s00439-019-02088-4","journal-title":"Hum Genet"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.3390\/genes11070747","article-title":"Precision and personalized medicine: how genomic approach improves the management of cardiovascular and neurodegenerative disease","volume":"11","author":"Strianese O","year":"2020","unstructured":"Strianese O, Rizzo F, Ciccarelli M, et al.. Precision and personalized medicine: how genomic approach improves the management of cardiovascular and neurodegenerative disease. Genes (Basel). 2020, 11:747. 10.3390\/genes11070747","journal-title":"Genes (Basel)"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacbts.2018.01.003","article-title":"Cardiovascular precision medicine in the genomics era","volume":"3","author":"Dainis AM","year":"2018","unstructured":"Dainis AM, Ashley EA. Cardiovascular precision medicine in the genomics era. JACC Basic Transl Sci. 2018, 3:313-26. 10.1016\/j.jacbts.2018.01.003","journal-title":"JACC Basic Transl Sci"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-023-02003-4","article-title":"The expansion of genetic testing in cardiovascular medicine: preparing the cardiology community for the changing landscape","volume":"26","author":"Reza N","year":"2024","unstructured":"Reza N, Alford RL, Belmont JW, Marston N. The expansion of genetic testing in cardiovascular medicine: preparing the cardiology community for the changing landscape. Curr Cardiol Rep. 2024, 26:135-46. 10.1007\/s11886-023-02003-4","journal-title":"Curr Cardiol Rep"},{"key":"ref69","unstructured":"Ethical, legal and social issues related to the offer of whole exome and whole genome sequencing. (2018). Accessed. June 11, 2025: https:\/\/amsdottorato.unibo.it\/id\/eprint\/8295\/1\/NIEMIEC_EMILIA_tesi.pdf."},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1007\/s12687-022-00625-9","article-title":"Ethical, legal, and social implications of genetic risk prediction for multifactorial disease: a narrative review identifying concerns about interpretation and use of polygenic scores","volume":"14","author":"Chapman CR","year":"2022","unstructured":"Chapman CR. Ethical, legal, and social implications of genetic risk prediction for multifactorial disease: a narrative review identifying concerns about interpretation and use of polygenic scores. J Community Genet. 2022, 14:441-52. 10.1007\/s12687-022-00625-9","journal-title":"J Community Genet"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1159\/000507056","article-title":"Return of research-related genetic test results and genetic discrimination concerns: facilitators and barriers of genetic research participation in diverse groups","volume":"23","author":"Burnett-Hartman AN","year":"2020","unstructured":"Burnett-Hartman AN, Blum-Barnett E, Carroll NM, et al.. Return of research-related genetic test results and genetic discrimination concerns: facilitators and barriers of genetic research participation in diverse groups. Public Health Genomics. 2020, 23:59-68. 10.1159\/000507056","journal-title":"Public Health Genomics"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1038\/s41436-020-00957-2","article-title":"Clinical and psychological outcomes of receiving a variant of uncertain significance from multigene panel testing or genomic sequencing: a systematic review and meta-analysis","volume":"23","author":"Mighton C","year":"2021","unstructured":"Mighton C, Shickh S, Uleryk E, Pechlivanoglou P, Bombard Y. Clinical and psychological outcomes of receiving a variant of uncertain significance from multigene panel testing or genomic sequencing: a systematic review and meta-analysis. Genet Med. 2021, 23:22-33. 10.1038\/s41436-020-00957-2","journal-title":"Genet Med"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1097\/GIM.0b013e3181cdde04","article-title":"Outcomes of interest in evidence-based evaluations of genetic tests","volume":"12","author":"Botkin JR","year":"2010","unstructured":"Botkin JR, Teutsch SM, Kaye CI, et al.. Outcomes of interest in evidence-based evaluations of genetic tests. Genet Med. 2010, 12:228-35. 10.1097\/GIM.0b013e3181cdde04","journal-title":"Genet Med"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1037\/hea0000683","article-title":"Behavioral impact of return of genetic test results for complex disease: Systematic review and meta-analysis","volume":"37","author":"Frieser MJ","year":"2018","unstructured":"Frieser MJ, Wilson S, Vrieze S. Behavioral impact of return of genetic test results for complex disease: Systematic review and meta-analysis. Health Psychol. 2018, 37:1134-44. 10.1037\/hea0000683","journal-title":"Health Psychol"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1007\/s10897-010-9307-z","article-title":"Misunderstandings concerning genetics among patients confronting genetic disease","volume":"19","author":"Klitzman RL","year":"2010","unstructured":"Klitzman RL. Misunderstandings concerning genetics among patients confronting genetic disease. J Genet Couns. 2010, 19:430-46. 10.1007\/s10897-010-9307-z","journal-title":"J Genet Couns"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1007\/s12687-013-0154-0","article-title":"Willingness to participate in genomics research and desire for personal results among underrepresented minority patients: a structured interview study","volume":"4","author":"Sanderson SC","year":"2013","unstructured":"Sanderson SC, Diefenbach MA, Zinberg R, et al.. Willingness to participate in genomics research and desire for personal results among underrepresented minority patients: a structured interview study. J Community Genet. 2013, 4:469-82. 10.1007\/s12687-013-0154-0","journal-title":"J Community Genet"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1186\/s12910-017-0175-z","article-title":"\"I passed the test!\" Evidence of diagnostic misconception in the recruitment of population controls for an H3Africa genomic study in Cape Town, South Africa","volume":"18","author":"Masiye F","year":"2017","unstructured":"Masiye F, Mayosi B, de Vries J. \"I passed the test!\" Evidence of diagnostic misconception in the recruitment of population controls for an H3Africa genomic study in Cape Town, South Africa. BMC Med Ethics. 2017, 18:12. 10.1186\/s12910-017-0175-z","journal-title":"BMC Med Ethics"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.2174\/011573403X299265240405080030","article-title":"Review on emerging therapeutic strategies for managing cardiovascular disease","volume":"20","author":"Narkhede M","year":"2024","unstructured":"Narkhede M, Pardeshi A, Bhagat R, Dharme G. Review on emerging therapeutic strategies for managing cardiovascular disease. Curr Cardiol Rev. 2024, 20:e160424228949. 10.2174\/011573403X299265240405080030","journal-title":"Curr Cardiol Rev"},{"key":"ref79","article-title":"Advances in precision medicine: targeted therapies and risk prediction models in cardiovascular disease management","volume":"17","author":"Senders S","year":"2023","unstructured":"Senders S. Advances in precision medicine: targeted therapies and risk prediction models in cardiovascular disease management. Health Sci J. 2023, 17:1062.","journal-title":"Health Sci J"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1111\/cge.12881","article-title":"Cardiovascular pharmacogenetics: a promise for genomically-guided therapy and personalized medicine","volume":"91","author":"Zaiou M","year":"2017","unstructured":"Zaiou M, El Amri H. Cardiovascular pharmacogenetics: a promise for genomically-guided therapy and personalized medicine. Clin Genet. 2017, 91:355-70. 10.1111\/cge.12881","journal-title":"Clin Genet"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1124\/pr.112.007252","article-title":"Pharmacogenetics and cardiovascular disease-implications for personalized medicine","volume":"65","author":"Johnson JA","year":"2013","unstructured":"Johnson JA, Cavallari LH. Pharmacogenetics and cardiovascular disease-implications for personalized medicine. Pharmacol Rev. 2013, 65:987-1009. 10.1124\/pr.112.007252","journal-title":"Pharmacol Rev"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.2174\/0113816128309440240427102903","article-title":"Personalized approaches to cardiovascular disease: insights into FDA-approved interventions and clinical pharmacogenetics","volume":"30","author":"Raoufinia R","year":"2024","unstructured":"Raoufinia R, Rahimi HR, Abbaszadeh M, et al.. Personalized approaches to cardiovascular disease: insights into FDA-approved interventions and clinical pharmacogenetics. Curr Pharm Des. 2024, 30:1667-80. 10.2174\/0113816128309440240427102903","journal-title":"Curr Pharm Des"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2023.102182","article-title":"Genomic insights into heart health: exploring the genetic basis of cardiovascular disease","volume":"49","author":"Safdar M","year":"2024","unstructured":"Safdar M, Ullah M, Wahab A, et al.. Genomic insights into heart health: exploring the genetic basis of cardiovascular disease. Curr Probl Cardiol. 2024, 49:102182. 10.1016\/j.cpcardiol.2023.102182","journal-title":"Curr Probl Cardiol"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1126\/science.1258096","article-title":"Genome editing. The new frontier of genome engineering with CRISPR-Cas9","volume":"346","author":"Doudna JA","year":"2014","unstructured":"Doudna JA, Charpentier E. Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science. 2014, 346:1258096. 10.1126\/science.1258096","journal-title":"Science"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek M","year":"2012","unstructured":"Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science. 2012, 337:816-21. 10.1126\/science.1225829","journal-title":"Science"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1186\/s40779-023-00447-x","article-title":"Recent advances in CRISPR-based genome editing technology and its applications in cardiovascular research","volume":"10","author":"Li ZH","year":"2023","unstructured":"Li ZH, Wang J, Xu JP, Wang J, Yang X. Recent advances in CRISPR-based genome editing technology and its applications in cardiovascular research. Mil Med Res. 2023, 10:12. 10.1186\/s40779-023-00447-x","journal-title":"Mil Med Res"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1139\/bcb-2019-0045","article-title":"The impact of epigenetics on cardiovascular disease","volume":"98","author":"Prasher D","year":"2020","unstructured":"Prasher D, Greenway SC, Singh RB. The impact of epigenetics on cardiovascular disease. Biochem Cell Biol. 2020, 98:12-22. 10.1139\/bcb-2019-0045","journal-title":"Biochem Cell Biol"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22168954","article-title":"Multiomic approaches to uncover the complexities of dystrophin-associated cardiomyopathy","volume":"22","author":"Gowran A","year":"2021","unstructured":"Gowran A, Brioschi M, Rovina D, et al.. Multiomic approaches to uncover the complexities of dystrophin-associated cardiomyopathy. Int J Mol Sci. 2021, 22:8954. 10.3390\/ijms22168954","journal-title":"Int J Mol Sci"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgg.2024.01.001","article-title":"Exploring noncoding variants in genetic diseases: from detection to functional insights","volume":"51","author":"Wu K","year":"2024","unstructured":"Wu K, Bu F, Wu Y, et al.. Exploring noncoding variants in genetic diseases: from detection to functional insights. J Genet Genomics. 2024, 51:111-32. 10.1016\/j.jgg.2024.01.001","journal-title":"J Genet Genomics"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2019.00009","article-title":"Multi-omics approaches to study long non-coding RNA function in atherosclerosis","volume":"6","author":"Turner AW","year":"2019","unstructured":"Turner AW, Wong D, Khan MD, Dreisbach CN, Palmore M, Miller CL. Multi-omics approaches to study long non-coding RNA function in atherosclerosis. Front Cardiovasc Med. 2019, 6:9. 10.3389\/fcvm.2019.00009","journal-title":"Front Cardiovasc Med"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1605086","article-title":"Genetic risk, adherence to a healthy lifestyle, and coronary disease","volume":"375","author":"Khera AV","year":"2016","unstructured":"Khera AV, Emdin CA, Drake I, et al.. Genetic risk, adherence to a healthy lifestyle, and coronary disease. N Engl J Med. 2016, 375:2349-58. 10.1056\/NEJMoa1605086","journal-title":"N Engl J Med"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-443-23802-4.00019-3","article-title":"Future challenges and prospects for personalized epigenetics","author":"Li Q","year":"2024","unstructured":"Li Q, Lei Y, Zhang P, Liu Y, Lu Q, Chang C. Future challenges and prospects for personalized epigenetics. Pers Epigenet, 2nd ed. Tollefsbol TO (ed): Academic Press, London; 2024. 721-44. 10.1016\/B978-0-443-23802-4.00019-3"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/366279-role-of-genetics-in-early-onset-cardiovascular-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T10:24:23Z","timestamp":1749896663000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/366279-role-of-genetics-in-early-onset-cardiovascular-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,14]]},"references-count":92,"URL":"https:\/\/doi.org\/10.7759\/cureus.85988","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,14]]}}}